Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 23 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

22%

4 of 18 completed trials have results

Key Signals

2 recruiting4 with results

Enrollment Performance

Analytics

N/A
10(83.3%)
Phase 1
1(8.3%)
Phase 2
1(8.3%)
12Total
N/A(10)
Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials
NCT01638390Phase 1Completed

Use of the VisuMax™ Femtosecond Laser

Role: lead

NCT05139277Not ApplicableRecruiting

Evaluation of the CONVIVO System

Role: collaborator

NCT06264232Not ApplicableCompleted

AT ELANA 841P Posterior Chamber Intraocular Lens for Correction of Aphakia Following Cataract Removal

Role: lead

NCT05740293Completed

Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

Role: lead

NCT02691923Phase 2Recruiting

Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker

Role: collaborator

NCT05729477Not ApplicableEnrolling By Invitation

A Prospective Multicenter Study To Assess The Clinical Outcomes Of Current Phacoemulsification Approach To Cataract Extraction Versus The Micor System Device

Role: lead

NCT04747834Not ApplicableCompleted

Assessment of Low Energy Lens Fragmentation Cataract Extraction in Patients Undergoing Cataract Surgery

Role: lead

NCT06216067Completed

Evaluate Performance of Callisto Eye vs. Wavetec AnalyzOR

Role: collaborator

NCT04072289Not ApplicableUnknown

SMILE (Small Incision Lenticule Extraction) in the DoD (Department of Defense)

Role: collaborator

NCT02430428Not ApplicableCompleted

Correction of Myopia Wtih or Without Astigmatism Using the VisuMax™ Femtosecond Laser

Role: lead

NCT00761826Not ApplicableCompleted

Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Mixed Astigmatism

Role: lead

NCT00762541Not ApplicableCompleted

Study of the MEL 80 Excimer Laser Using LASIK in the Treatment of Moderate to High Myopia

Role: lead

NCT03518775Completed

Repeatability and Reproducibility of the IOLMaster 700 Vers 1.70 and Agreement With IOLMaster 700 Vers. 1.50 and Pentacam

Role: lead

NCT02160340Completed

Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older

Role: collaborator

NCT01234207Not ApplicableCompleted

Clinical Assessment of a Customized Free-form Progressive Addition Lens Spectacle

Role: collaborator

NCT02708082Unknown

Glaucoma HFA / OCT Specificity Study

Role: lead

NCT00396188Completed

Screening Aid to Identify Corneas That May Have Pathologies or Other Conditions

Role: lead

NCT01272076Completed

Cirrus HD-OCT Measurement of Area of Increased Light Penetration Under the Retinal Pigment Epithelium (RPE)

Role: lead

NCT01890174Completed

Repeatability and Reproducibility of Cirrus HD-OCT Macular Retinal Pigment Epithelium Elevation

Role: lead

NCT01890187Completed

Repeatability and Reproducibility of Cirrus HD-OCT Measurements of Illumination Areas Under the Retinal Pigment Epithelium

Role: lead